Market Research Report
Global Orthokeratology Lens Market Research Report Forecast to 2025
|Published by||Market Research Future||Product code||916688|
|Published||Content info||95 Pages
Delivery time: 1-2 business days
|Global Orthokeratology Lens Market Research Report Forecast to 2025|
|Published: October 31, 2019||Content info: 95 Pages||
Global Orthokeratology Lens Market: Information by Material (Silicone Acrylate, Fluorosilicone Acrylate and Fluorocarbon Acrylate), Application (Myopia and Hyperopia), End User (Hospitals and Ophthalmic Clinic) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025
Generally, Orthokeratology is also known as ortho-k, corneal refractive therapy (CRT), and overnight vision correction therapy. It is a non-surgical method used to correct refractive errors by reshaping the curvature of the cornea to improve object visibility. This method is a transitory medication method used for the correction of myopia, hypermetropia, and other eye-related problems. A rise in the number of individuals with refractive errors such as myopia, hypermetropia, astigmatism, and presbyopia increases the requirement for pioneering treatment approaches. Myopia is released as the most frequent disorder concerning several populations worldwide. Ortho-K is a non-surgical refractive treatment. In order to rectify your short-sightedness and astigmatism, the cornea must be re-shaped. The categorization of Orthokeratology Lens includes Boston Material, Paragon Material and Others Material, and the proportion of Boston Material in 2016 is about 84%, and the proportion is in steady from years 2012 to year 2016. Our optometrists tailor your Ortho-k lenses with highly porous lens materials corresponding to the precise measurement by the Corneal Topographer. The World Health Organization 2018 fact sheet estimated that around 1.3 billion people were living with some form of vision damage. It also reported that 188.5 million patients have a mild vision impairment, 217 million people have slight to severe vision damage, and 36 million people are blind, globally. Such a vast population despair from eye problems adjusts market increase during the projected interval.
The Global Orthokeratology Lens Market has been segmented by type, application and by region. By Material it is given by Silicone Acrylate, Fluorosilicone Acrylate, Fluorocarbon Acrylate. By Application it I given by Myopia and Hyperopia. Among the various applications, myopia holds the leading market share in 2018 and is expected to grow at a CAGR of 11.6% over the forecast period which is highest among other applications. This is due to the surge in the prevalence rates of vision impairment across distinct regions of the world amplifying across all age groups. Market rivalry is extreme. Autek, EUCLID, Paragon, Alpha Corporation, Lucid Korea, Brighten Optix, Contex and Procornea are the leaders of the industry, and they hold key technologies and patents, with high-end patrons; have been molded in the domination position in the industry. The rising frequency of refractive faults across the globe, advancements in the field of ophthalmology over the past couple of decades and low cost related to laser-assisted in situ keratomileuses (LASIK) treatment is expected to enhance the market growth. However, the availability of complementary medicine approaches and risk linked with orthokeratology are predicted to curb the growth of the market. High acceptance rates have been stated across United States, Israel, China, Europe, Australia, and other Asian countries. For instance, myopic macular degeneration (MMD) is the main reason of perpetual monocular recklessness in Japan and there are new incidents of blindness in Shanghai that have been described. A newest analysis predicted that myopia and high myopia is likely to affect 5 billion and 1 billion people, correspondingly, by the year 2050. This alarming data indicates the urgent necessity on managing myopia. Over the years, numerous medications have been performed with an aim to suppress myopia, out of which, orthokeratology lens has demonstrated to be one of the most effective process with least consequences.
Geographically, Global Orthokeratology Lens Market is split in regions like North & Latin America, Europe, Asia-Pacific, Middle east and Africa and Rest of the world. Asia-Pacific is anticipated to account for the second-largest market share during the forecast cycle. The features accountable for market evolution in this region are the mounting patient inhabitants of people with eye disorders, obtainability of advanced treatment facilities, increasing healthcare expenditure, and the introduction of advanced therapies into the market along with the attendance of good healthcare structure. According to the Asian Development Bank, the elderly population in Asia is estimated to reach nearly arund 923 million by 2050. The orthokeratology lens market in the Middle East & Africa is expected to present the least growth in the global orthokeratology lens market due to considerations such as limited access to healthcare affordability issues. Europe is estimated to be growing at the fastest pace in the global market due to the increasing cases of eye disorders and increasing government initiatives are driving the growth of the market. Corresponding to reports published by the United Kingdom Statistics Authority, in 2015, around 15,900 people were recorded as visually compromised. The Americas is expected to hold the largest share of the global orthokeratology lens market. The increase of the Americas can be credited to its growing population and rising ophthalmological disorders, causing an expanded need for diagnosis and medicinal.
The proposed spectators in the Global Orthokeratology Lens Market are Medical device companies, manufacturers, Retailers, distributors, wholesalers, Investors and trade experts, Governments, associations, industrial bodies, etc. The major companies functioning in the Global Orthokeratology Lens Market are concentrating on firming their global ways by entering into untouched markets. The projected onlookers in the Global Orthokeratology Lens Market are companies like Procornea (CooperVision) (Eerbeek, Netherlands), Bausch & Lomb Incorporated (US), CooperVision (US), CE GP Specialists (US), Menicon Co., Ltd (Japan), Visioneering Technologies, Inc. (VTI) (Georgia), Brighten Optix (Taiwan), Alcon, Inc. (Texas), CONTAMAC (Essex) and Euclid Systems Corporation (Virginia).